These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6307048)

  • 1. The role of sodium intake, the Na+-K+ pump and a ouabain-like humoral agent in the genesis of reduced renal mass hypertension.
    Huot SJ; Pamnani MB; Clough DL; Haddy FJ
    Am J Nephrol; 1983; 3(2-3):92-9. PubMed ID: 6307048
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased myocardial Na+-K+-ATPase activity in one-kidney, one-clip hypertensive rats.
    Clough DL; Pamnani MB; Haddy FJ
    Am J Physiol; 1983 Aug; 245(2):H244-51. PubMed ID: 6136190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs.
    Overbeck HW; Pamnani MB; Akera T; Brody TM; Haddy FJ
    Circ Res; 1976 Jun; 38(6 Suppl 2):48-52. PubMed ID: 131655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension.
    Clough DL; Huot SJ; Pamnani MB; Haddy FJ
    J Hypertens; 1985 Dec; 3(6):583-9. PubMed ID: 3003189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Na+-K+ pump activity in erythrocytes and blood pressure in anephric rats.
    Birbari AE; Hajj-Ali AF; Mukaddam-Daher SS; Jirjus AR
    J Hypertens Suppl; 1988 Dec; 6(4):S264-5. PubMed ID: 2853734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertension.
    Cloix JF; Crabos M; Devynck MA; Elghozi JL; Henning G; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB
    Adv Nephrol Necker Hosp; 1985; 14():161-71. PubMed ID: 2579533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-potassium pump in low-renin hypertension.
    Haddy FJ
    Ann Intern Med; 1983 May; 98(5 Pt 2):781-4. PubMed ID: 6303176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats.
    Ku DD; Meezan E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):664-70. PubMed ID: 6144789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular Na+-K+ pump in low renin hypertension.
    Haddy FJ; Pamnani MB
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S61-74. PubMed ID: 6204161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of a humoral sodium-potassium pump inhibitor in experimental low renin hypertension.
    Haddy FJ; Pamnani M; Clough D; Huot S
    Life Sci; 1982 Feb 15-22; 30(7-8):571-5. PubMed ID: 6280009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of canrenone on blood pressure in rats with reduced renal mass.
    Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ
    Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sodium-potassium pump in volume expanded hypertension.
    Haddy F; Pamnani M; Clough D
    Clin Exp Hypertens (1978); 1978-1979; 1(3):295-336. PubMed ID: 387359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of the Na+, K+, and ATP binding sites of the ouabain-complexed (Na+ + K+)-ATPase: implications for the mechanism of ouabain action.
    Kakar SS; Huang WH; Askari A
    Prog Clin Biol Res; 1988; 268A():211-8. PubMed ID: 2843864
    [No Abstract]   [Full Text] [Related]  

  • 16. The kidney in potassium depletion. I. Na+-K+-ATPase activity and [3H]ouabain binding in MCT.
    Hayashi M; Katz AI
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F437-46. PubMed ID: 3030136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Presence of "reserve" Na-K-ATPase molecules in cell membranes].
    Aĭrapetian SN; Dadalian SS; Marikian GG; Avetisian GA; Gevorkian AM
    Dokl Akad Nauk SSSR; 1981; 258(4):1003-6. PubMed ID: 6265183
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical and clinical studies of endogenous digitalis-like factor in hypertension.
    Cloix JF; Devynck MA; Meyer P
    Ann N Y Acad Sci; 1986; 488():217-27. PubMed ID: 2437846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na-K pump site density and ouabain binding affinity in cultured chick heart cells.
    Lobaugh LA; Lieberman M
    Am J Physiol; 1987 Nov; 253(5 Pt 1):C731-43. PubMed ID: 2446503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The sodium-potassium pump in hypertension. Mechanisms of action of potassium].
    Haddy FJ
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():67-72. PubMed ID: 6329119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.